HSPB8
Basic information
Region (hg38): 12:119171555-119224855
Links
Phenotypes
GenCC
Source:
- Charcot-Marie-Tooth disease axonal type 2L (Supportive), mode of inheritance: AD
- distal hereditary motor neuropathy type 2 (Supportive), mode of inheritance: AD
- autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome (Supportive), mode of inheritance: AD
- neuronopathy, distal hereditary motor, type 2A (Strong), mode of inheritance: AD
- Charcot-Marie-Tooth disease axonal type 2L (Strong), mode of inheritance: AD
- neuronopathy, distal hereditary motor, autosomal dominant (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Charcot-Marie-Tooth disease, axonal, type 2L; Neuronopathy, distal hereditary motor, autosomal dominant 2 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 1517763; 15122253; 15021985; 15565283; 18325928; 20538880; 21985219 |
ClinVar
This is a list of variants' phenotypes submitted to
- Charcot-Marie-Tooth disease axonal type 2L (4 variants)
- not provided (2 variants)
- Neuronopathy, distal hereditary motor, type 2A (1 variants)
- Charcot-Marie-Tooth disease (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HSPB8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 38 | 43 | ||||
missense | 104 | 114 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 11 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 14 | 12 | 15 | 41 | ||
Total | 4 | 6 | 129 | 54 | 19 |
Variants in HSPB8
This is a list of pathogenic ClinVar variants found in the HSPB8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-119178480-T-C | Benign (May 06, 2019) | |||
12-119178591-A-G | Benign (May 06, 2019) | |||
12-119178791-C-G | Charcot-Marie-Tooth disease axonal type 2L • Neuronopathy, distal hereditary motor, type 2A | Uncertain significance (Nov 15, 2017) | ||
12-119178824-G-A | Charcot-Marie-Tooth disease axonal type 2L • Neuronopathy, distal hereditary motor, type 2A | Uncertain significance (Jan 12, 2018) | ||
12-119178833-C-G | Neuronopathy, distal hereditary motor, type 2A • Charcot-Marie-Tooth disease axonal type 2L | Uncertain significance (Jan 13, 2018) | ||
12-119178856-A-G | Neuronopathy, distal hereditary motor, type 2A • Charcot-Marie-Tooth disease axonal type 2L | Benign (Jan 13, 2018) | ||
12-119178894-A-T | Neuronopathy, distal hereditary motor, type 2A • Charcot-Marie-Tooth disease axonal type 2L | Uncertain significance (Jan 12, 2018) | ||
12-119178999-T-C | Charcot-Marie-Tooth disease axonal type 2L • Neuronopathy, distal hereditary motor, type 2A | Uncertain significance (Jan 13, 2018) | ||
12-119179112-G-T | Neuronopathy, distal hereditary motor, type 2A • Charcot-Marie-Tooth disease axonal type 2L | Uncertain significance (Jan 12, 2018) | ||
12-119179120-T-C | Neuronopathy, distal hereditary motor, type 2A • Charcot-Marie-Tooth disease axonal type 2L | Benign (Jun 16, 2018) | ||
12-119179141-G-C | Charcot-Marie-Tooth disease axonal type 2L • Neuronopathy, distal hereditary motor, type 2A | Uncertain significance (Jan 12, 2018) | ||
12-119179278-T-A | not specified | Likely benign (Dec 08, 2015) | ||
12-119179321-C-G | Charcot-Marie-Tooth disease axonal type 2L | Uncertain significance (Mar 02, 2017) | ||
12-119179322-G-A | Charcot-Marie-Tooth disease axonal type 2L | Uncertain significance (Nov 19, 2023) | ||
12-119179323-G-A | Charcot-Marie-Tooth disease axonal type 2L | Uncertain significance (Dec 22, 2020) | ||
12-119179326-A-G | Charcot-Marie-Tooth disease axonal type 2L • Charcot-Marie-Tooth disease axonal type 2L;Neuronopathy, distal hereditary motor, type 2A • Neuronopathy, distal hereditary motor, type 2A • Inborn genetic diseases | Conflicting classifications of pathogenicity (Sep 26, 2023) | ||
12-119179329-T-C | Charcot-Marie-Tooth disease axonal type 2L | Uncertain significance (Nov 22, 2023) | ||
12-119179333-C-A | Charcot-Marie-Tooth disease axonal type 2L | Likely benign (Feb 26, 2019) | ||
12-119179337-T-C | Charcot-Marie-Tooth disease | Uncertain significance (Aug 14, 2019) | ||
12-119179338-C-T | Charcot-Marie-Tooth disease axonal type 2L | Uncertain significance (Nov 27, 2023) | ||
12-119179339-CT-GG | Charcot-Marie-Tooth disease axonal type 2L | Uncertain significance (Jan 28, 2024) | ||
12-119179344-A-C | Charcot-Marie-Tooth disease axonal type 2L | Uncertain significance (Oct 27, 2023) | ||
12-119179344-A-G | Uncertain significance (Sep 14, 2015) | |||
12-119179351-A-G | Charcot-Marie-Tooth disease axonal type 2L | Likely benign (Sep 20, 2022) | ||
12-119179355-C-T | Charcot-Marie-Tooth disease axonal type 2L | Uncertain significance (Oct 10, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HSPB8 | protein_coding | protein_coding | ENST00000281938 | 3 | 42490 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0431 | 0.858 | 125743 | 0 | 5 | 125748 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0269 | 110 | 111 | 0.993 | 0.00000612 | 1270 |
Missense in Polyphen | 32 | 37.2 | 0.86021 | 464 | ||
Synonymous | -0.464 | 47 | 43.1 | 1.09 | 0.00000239 | 404 |
Loss of Function | 1.35 | 3 | 6.78 | 0.442 | 3.45e-7 | 70 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000354 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Displays temperature-dependent chaperone activity.;
- Disease
- DISEASE: Neuronopathy, distal hereditary motor, 2A (HMN2A) [MIM:158590]: A neuromuscular disorder. Distal hereditary motor neuronopathies constitute a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs. {ECO:0000269|PubMed:15122253, ECO:0000269|PubMed:28144995}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease 2L (CMT2L) [MIM:608673]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:15565283}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.221
Intolerance Scores
- loftool
- 0.229
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 67.92
Haploinsufficiency Scores
- pHI
- 0.556
- hipred
- Y
- hipred_score
- 0.706
- ghis
- 0.505
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.980
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hspb8
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; immune system phenotype;
Gene ontology
- Biological process
- protein phosphorylation;cellular response to unfolded protein;regulation of cellular response to heat;positive regulation of aggrephagy
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol;chaperone complex
- Molecular function
- protein kinase activity;protein binding;identical protein binding;protein homodimerization activity